Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 56.52M | 58.88M | 30.8M | 29.12M | 25.82M | 30.06M | 31.82M | 31.97M | 33.87M | 23.44M | 24.56M | 17.95M | 11.45M |
Cost of Revenue | 22.89M | 576K | 573K | 575K | 589K | 597K | 590K | 18.75M | 33.23M | 43.52M | 52.44M | 40.28M | 32.74M |
Gross Profit | 33.63M | 58.3M | 30.23M | 28.55M | 25.23M | 29.47M | 31.23M | 13.22M | 639K | -20.07M | -27.88M | -22.33M | -21.3M |
Operating Income | -51.35M | -44.25M | -66.17M | -65.45M | -66.28M | -58.15M | -53.15M | -52.59M | -46.83M | -49.86M | -40.94M | -34.65M | -33.67M |
Interest Income | 14.21M | 11.85M | 10M | 7.78M | 5.56M | 3.29M | 1.22M | 604K | 341K | 259K | 457K | 416K | 409K |
Pretax Income | -36.73M | -32.08M | -56.46M | -58.01M | -61.17M | -55.43M | -52.58M | -52.72M | -47.3M | -50.42M | -41.3M | -34.02M | -33.06M |
Net Income | -36.84M | -29.93M | -54.75M | -55.74M | -60.69M | -57.2M | -53.51M | -54.29M | -47.22M | -50.33M | -41.51M | -34.15M | -33.05M |
Selling & General & Admin | 24.09M | 22.22M | 20.24M | 19.4M | 18.59M | 17.97M | 18.12M | 16.98M | 16.08M | 14.56M | 13.06M | 12.32M | 12.38M |
Research & Development | 83.63M | 80.76M | 76.73M | 75.17M | 73.51M | 70.24M | 66.85M | 67.57M | 64.62M | 58.74M | 52.44M | 40.28M | 32.74M |
Other Expenses | -64K | -86K | -111K | -48K | -62K | -97K | -76K | -76K | -61K | -4K | 43K | 1.08M | 1.08M |
Operating Expenses | 107.73M | 102.98M | 96.97M | 94.57M | 92.1M | 88.21M | 84.97M | 84.55M | 80.69M | 73.3M | 65.5M | 52.6M | 45.12M |
Interest Expense | 28K | 98K | 185K | 290K | 392K | 476K | 567K | 665K | 753K | 816K | 853K | 864K | 872K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 107.88M | 103.13M | 96.97M | 94.57M | 92.1M | 88.21M | 84.97M | 84.55M | 80.69M | 73.3M | 65.5M | 52.6M | 45.12M |
Income Tax Expense | 67K | -2.19M | -1.74M | -2.24M | -489K | 1.77M | 925K | 1.56M | -83K | -24K | 274.01K | 194.01K | 57.01K |
Shares Outstanding (Basic) | 64.03M | 60.35M | 49.22M | 48.05M | 47.57M | 45.88M | 31.57M | 30.32M | 30.27M | 29.14M | 24.72M | 23.91M | 23.87M |
Shares Outstanding (Diluted) | 64.03M | 60.35M | 49.22M | 48.05M | 47.57M | 45.88M | 31.57M | 30.32M | 30.27M | 29.35M | 24.72M | 23.91M | 23.87M |
EPS (Basic) | -0.69 | -0.64 | -1.15 | -1.31 | -1.64 | -1.66 | -1.77 | -1.92 | -1.78 | -1.98 | -1.73 | -1.46 | -1.53 |
EPS (Diluted) | -0.69 | -0.64 | -1.15 | -1.31 | -1.64 | -1.66 | -1.77 | -1.92 | -1.78 | -1.98 | -1.73 | -1.46 | -1.53 |
EBITDA | -45.42M | -36.06M | -55.99M | -57.43M | -60.48M | -54.5M | -51.56M | -51.6M | -46.08M | -49.12M | -39.96M | -32.69M | -31.73M |
EBIT | -29.96M | -20.46M | -44.55M | -57.72M | -60.78M | -54.96M | -52.01M | -52.06M | -46.55M | -49.6M | -40.44M | -33.16M | -32.18M |
Depreciation & Amortization | 583K | 2.83M | 4.82M | 5.49M | 5.8M | 3.64M | 1.64M | 984K | 691K | 620K | 641K | 626K | 608K |